Efficacy of Interleukin-1β Inhibitor on Dry Eye Disease in Patients with Degenerative Arthritis

PURPOSE: To evaluate diacerein (interleukin-1β inhibitor) efficacy on ocular surface disease (OSD). PATIENTS AND METHODS: This prospective observational study included patients who received diacerein for osteoarthritis and had dry eye (DE). The primary outcome was corneal staining score. Secondary o...

Descripción completa

Detalles Bibliográficos
Autores principales: Treewipanon, Nathapon, Kasetsuwan, Ngamjit, Reinprayoon, Usanee, Satitpitakul, Vannarut, Uthaithammarat, Lita, Tanpowpong, Thanathep
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10573358/
https://www.ncbi.nlm.nih.gov/pubmed/37841899
http://dx.doi.org/10.2147/OPTH.S419310

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10573358/
https://www.ncbi.nlm.nih.gov/pubmed/37841899
http://dx.doi.org/10.2147/OPTH.S419310

Ejemplares similares